2 studies found for:    15564544 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Providing Access to Cord Blood Units for Transplants
Conditions: Chronic Myelogous Leukemia/Other Leukemia;   Acute Leukemias;   MDS/MPS;   Multiple Myeloma;   Non-Hodgkin Lymphoma
Intervention: Drug: Access to unlicensed cord blood units
2 Terminated Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Conditions: Leukemia;   Non-Hodgkins Lymphoma;   Hodgkins Lymphoma;   MDS;   Multiple Myeloma
Interventions: Drug: EPOCH-F/R;   Drug: FLAG;   Drug: Transplant Preparative Regimen (Flu/Cy/Mes);   Drug: GVHD Prophylaxis (tacrolimus and sirolimus);   Procedure: Double Cord Blood Transplantation

Indicates status has not been verified in more than two years